LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
© LexDana · beta
LexDanaLexDanabeta
New SessionDrug SearchOfficial RankingsInsights
LexDanaLexDanabeta

Insights

Analysis of patent litigation, PTAB practice, prosecution and pharma IP, written on the data behind LexDana.

AllCopyright & Trade Secrets59Federal Circuit877ITC / Section 33788Patent Litigation216Patent Prosecution126Pharma & ANDA62PTAB686Supreme Court61Trademark158USPTO Policy78Unsorted257

Tagged drug delivery methods · clear

Pharma & ANDA

The Benefits and Effects of Hatch- Waxman Act Four Decades Later

In early 1983, Bolar Pharmaceutical Inc. wanted to bring a generic version of the Dalmane drug, a sleeping pill, to the market. At that time, Roche Products Inc. held patent rights for flurazepam hydrochloride, the active ingredient in the drug.…

July 27, 2022·Pharma & ANDA·4 min read
Pharma & ANDA

How Do Patents Affect The Healthcare Industry?

Global health care spending is predicted to reach $10 trillion USD during 2022 with almost 30% of it belonging to the USA. It might sound like a good industry to be in, but keep in mind that the costs of developing a new drug range from $300 million up to…

May 1, 2022·Pharma & ANDA·2 min read
Patent Litigation

Lawsuit against generic lidocaine patches

ACTION : Infringement of U.S. Patent 5,827,529 (referred to as “529 Patent) by Noven Therapeutics/ Noven Pharmaceuticals , makers of products such as the ADHD drug Daytrana, at a considerable harm to the transdermal drug delivery technology company…

August 14, 2012·Patent Litigation·3 min read
Data: FDA Orange & Purple Books · prosecution & litigation metadata · read-only.